Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and continuously poses a serious threat to public health, highlighting the urgent need of identifying biomarkers for disease sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Shen, Chenguang, Li, Jinxiu, Yuan, Jing, Wei, Jinli, Huang, Fengmin, Wang, Fuxiang, Li, Guobao, Li, Yanjie, Xing, Li, Peng, Ling, Yang, Minghui, Cao, Mengli, Zheng, Haixia, Wu, Weibo, Zou, Rongrong, Li, Delin, Xu, Zhixiang, Wang, Haiyan, Zhang, Mingxia, Zhang, Zheng, Gao, George F., Jiang, Chengyu, Liu, Lei, Liu, Yingxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2020
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189843/
https://www.ncbi.nlm.nih.gov/pubmed/32360286
http://dx.doi.org/10.1016/j.jaci.2020.04.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189843/
https://www.ncbi.nlm.nih.gov/pubmed/32360286
http://dx.doi.org/10.1016/j.jaci.2020.04.027

Ejemplares similares